HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Natural Products Expo East In Brief

This article was originally published in The Tan Sheet

Executive Summary

Nordic Naturals contributes to fish oil research, expands vegetarian offerings; Boiron taps into medical community for more support of homeopathics; PCG’s Janica Lane remains bullish on health and wellness investments; recycled paperboard steps up in consumer goods packaging.

You may also be interested in...



Interview: Health & Wellness Investment Bank PCGA Prioritizes Supplement Innovation, Quality

Investment capital has followed the flood of consumer interest in the natural health and wellness market. Partnership Capital Growth Advisors was founded as an investment bank and financial advisor in 2005 to focus precisely on the "healthy, active and sustainable living" segment.

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

NaZura’s Lovidia Weight-Loss Supplement Strategy Focused On Brand Building

NaZura BioHealth, spun out from Elcelyx Therapeutics, will market its Lovidia weight-loss product in 2014 when it launches into the direct-response channel, before potential suitors get serious about acquiring the brand.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS125063

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel